In order to assess the clinical significance of the results, serum concentrations of these proteins were correlated to an indirect measure of the stroke severity (NIHss), S100β concentration on day 3, which is an indicator of the size of cerebral infarct, [26,27] as well as the outcome of the disease expressed by the modified Rankin scale. This evidence concerns the gene S100B and brain infarction.